Vertex and CRISPR Therapeutics announce USFDA approval of Casgevy for treatment of sickle cell disease
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Minister was briefed on the nationwide dengue situation
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Take proper precautions and seek timely treatment!
PEEK brings a new quality to dental care for patients
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
elanese now offers Zytel Resin, Hytrel TPC, Crastin PBT and Micromax Electronic Inks and Paste following its 2022 acquisition of the majority of the Mobility & Materials (M&M) business from DuPont
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Subscribe To Our Newsletter & Stay Updated